TANG CAPITAL PARTNERS LP 13D/13G Filings for Heron Therapeutics, Inc. (HRTX)

TANG CAPITAL PARTNERS LP 13D and 13G filings for Heron Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-14
4:00 pm
Sale		2022-12-3113GHeron Therapeutics, Inc.
HRTX		TANG CAPITAL PARTNERS LP3,756,694
3.200%		-4,026,994decrease
(-51.74%)		Filing
2022-02-14
4:00 pm
Purchase		2021-12-3113GHeron Therapeutics, Inc.
HRTX		TANG CAPITAL PARTNERS LP7,783,688
7.600%		144,588increase
(+1.89%)		Filing
2021-02-16
4:15 pm
Sale		2020-12-3113GHeron Therapeutics, Inc.
HRTX		TANG CAPITAL PARTNERS LP7,639,100
7.800%		-2,110,244decrease
(-21.64%)		Filing
2020-11-19
4:00 pm
Purchase		2008-10-1413GHeron Therapeutics, Inc.
HRTX		TANG CAPITAL PARTNERS LP9,749,344
9.990%		169,415increase
(+1.77%)		Filing